S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea · Delayed Price · Currency is KRW 20,550
-200 (-0.96%)
At close: Jul 6, 2026
S.Biomedics Market Cap
S.Biomedics has a market cap or net worth of 250.8 billion as of July 7, 2026. Its market cap has decreased by -0.25% in one year.
Market Cap
250.80B
Enterprise Value
261.31B
Revenue
16.48B
Ranking
n/a
PE Ratio
n/a
Stock Price
20,550.00
Market Cap Chart
Since May 4, 2023, S.Biomedics's market cap has increased from 206.56B to 250.80B, an increase of 21.42%. That is a compound annual growth rate of 6.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 254.51B | -43.87% |
| Dec 30, 2025 | 453.47B | 123.16% |
| Dec 30, 2024 | 203.20B | 55.86% |
| Dec 28, 2023 | 130.38B | -36.88% |
| May 4, 2023 | 206.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IntoCell | 345.51B |
| HansBiomed | 328.72B |
| IMBiologics | 309.40B |
| Kangstem Biotech | 257.71B |
| curacle co.,ltd. | 245.00B |
| NIBEC | 189.73B |
| Kanaph Therapeutics | 182.52B |
| Ensol Biosciences | 177.32B |